Protection against Mycobacterium tuberculosis challenge in mice by DNA vaccine Ag85A-ESAT-6-IL-21 priming and BCG boosting

International Journal of Immunogenetics

Volumn 39, Issue 2, 2012, Pages 183-190

  Dou, J ^a   Wang, Y ^a   Yu, F ^a   Yang, H ^b   Wang, J ^a   He, X ^a   Xu, W ^b   Chen, J ^a   Hu, K ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b Heilongjiang Provincial Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN 85 A AND 6 KDA EARLY SECRETORY ANTIGEN TARGET; BACTERIAL ANTIGEN; BCG VACCINE; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN A; INTERLEUKIN 21; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL LOAD; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; IMMUNIZATION; INFECTION PREVENTION; LUNG; LUNG LAVAGE; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SUPERNATANT; TUBERCULOSIS;

ACYLTRANSFERASES; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL LOAD; BACTERIAL PROTEINS; BCG VACCINE; CYTOTOXICITY TESTS, IMMUNOLOGIC; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INTERFERON-GAMMA; INTERLEUKINS; KILLER CELLS, NATURAL; LUNG; MALE; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TUBERCULOSIS; VACCINES, DNA;

BACTERIA (MICROORGANISMS); MUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 84858071905     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2011.01066.x     Document Type: Article

References (31)

1. Banerjee, S., Nandyala, A. & Podili, R. (2004) Mycobacterium tuberculosis (Mtb) isocitrate dehydrogenases show strong B cell response and distinguish vaccinated with controls from TB patients. Proceedings of the National Academy of Sciences of the United States of America, 101, 12652.
2. Bastian, A., Tunkel, C., Lins, M. Böttcher, H., Hirt, S.W., Cremer, J. & Bewig, B. (2000) Immunoglobulin A and secretory immunoglobulin A in the bronchoalveolar lavage from patients after lung transplantation. Clinical Transplantation, 6, 580.
3. Claire, S.A., Jes, D. & Else, M.A. (2007) The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis. Infection and Immunity, 75, 408.
4. Davis, S.S. (2001) Nasal vaccines. Advanced Drug Delivery Reviews, 51, 21.
5. Dietrich, J., Andersen, C., Rappuoli, R., Doherty, T.M., Jensen, C.G. & Andersen, P. (2006) Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior Bacillus Calmette-Gue′rin immunity. Journal of Immunology, 177, 6353.
6. Dormans, J., Burger, M. & Aguilar, D. (2004) Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model. Clinical and Experimental Immunology, 137, 468.
7. Dou, J., Tang, Q., Zhao, F.S., Chu, L.L., Chen, J.S., Cao, M.G., Liu, C.S., Wang, Y.F., Li, Y.T. & Li, J.L. (2008) Comparison of immune responses induced in mice by vaccination with DNA vaccine constructs expressing Mycobacterial antigen 85A & Interleukin-21 and Bacillus Galmette-Guérin. Immunological Investigations, 37, 127.
8. Dou, J., Tang, Q., Fangliu, Y., Haitao, Y., Fengshu, Z., Weiguo, X., Kai, H., Weihua, H. & Chunsheng, L. (2010) Investigation of immunogenic effect of the BCG priming and Ag85A GM-CSF boosting in Balb/c mice model. Immunobiology, 215, 42.
9. Espinal, M.A., Laszlo, A., Simonsen, L., Dye, C., Williams, R. & Raviglione, M.C. (2001) Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against tuberculosis and lung disease working group on anti-tuberculosis drug resistance surveillance. The New England Journal of Medicine, 344, 1214.
10. Glaziou, P., Floyd, K., Korenromp, E.L., Sismanidis, C., Bierrenbach, A.L., Williams, B.G., Atun, R. & Raviglione, M. (2011) Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality. Global burden and epidemiology of tuberculosis. Bulletin of the World Health Organization, 89, 573.
11. Hall, L.J., Clare, S. & Dougan, G. (2010) NK cells influence both innate and adaptive immune responses after mucosal immunization with antigen and mucosal adjuvant. Journal of Immunology, 184, 4337.
12. Huygen, K. (2006) DNA vaccines against mycobacterial diseases. Future Microbiology, 1, 63-73.
13. Jeon, B.Y., Kim, H.J., Kim, S.C., Jo, E.K., Park, J.K., Paik, T.H., Kim, S.J. & Cho, S.N. (2008) Protection of mice against Mycobacterium tuberculosis infection by immunization with aqueous fraction of Triton X-100-soluble cell wall proteins. Scandinavian Journal of Immunology, 67, 18.
14. Jian, W., Jun, X., Chuang, C., Gao, X., Li, L. & Zhong, N. (2009) Ag85B DNA vaccine suppresses airway inflammation in a murine model of asthma. Respiratory Research, 10, 51.
15. Jinlong, L., Fangliu, Y. & Jun, D. (2009) Constructing nucleic acid vaccine expressing fusion antigens of Mycobacterium tuberculosis Ag85A and ESAT-6, and Interleukin 21 as well as studying its immune effect in mice. Letters Biotechnology, 20, 800.
16. Jun, D., Pengbo, L. & Xinjian, Z. (2005) Cellular response to gene expression profiles of different hepatitis C virus core proteins in the Huh-7 cell line with microarray analysis. Journal of Nanoscience Nanotechnology, 5, 209.
17. Jun, D., Pengbo, L., Jing, W. & Xinjian, Z. (2006a) Effect of hepatitis C virus core shadow protein expressed in human hepatoma cell line on human gene expression profiles. Journal of Gastroenterology and Hepatology, 21, 1800.
18. Jun, D., Xiaowu, H., Fengshu, Z., Wang, J., Chen, J.S. & Chen, G.B. (2006b) Investigation of GM-CSF immune accessory effects in tumor-bearing mice by direct gene immunization. Immunological Investigations, 35, 227.
19. Jun, D., Lili, C., Fengshu, Z., Li, Y., Cao, M. & Gu, N. (2007) Study of immunotherapy of murine myeloma by an IL-21-based tumor vaccine in BALB/c mice. Cancer Biology and Therapy, 6, 1871.
20. Kaufmann, S.H. & McMichael, A.J. (2005) Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nature Medicine, 11, S33.
21. Kim-Schulze, S., Kim, H.S., Fan, Q., Kim, D.W. & Kaufman, H.L. (2009) Local IL-21 promotes the therapeutic activity of effector T cells by decreasing regulatory T cells within the tumor microenvironment. Molecular Therapy, 17, 380.
22. Mosmann, T.R. (1983) Colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 63.
23. Radosevic, K., Wieland, C.W. & Rodri′guez, A. (2007) Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon. Infection and Immunity, 75, 4105.
24. von Reyn, C.F. & Vuola, J.M. (2002) New vaccine for the prevention of tuberculosis. Clinical Infectious Diseases, 35, 465.
25. Russell, D.G., Rarry, C.E. & Flynn, J.L. (2010) Tuberculosis: what we don't know can, and does, hurt us. Science, 328, 852.
26. Sadagopal, S., Braunstein, M., Hager, C.C., Blackwell, T.S., Kalams, S.A. & Kernodle, D.S. (2009) Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG. PLoS One, 4, e5531.
27. Svenson, S., Källenius, G.P., Awlowski, A. & Hamasur, B. (2010) Towards new tuberculosis vaccines. Human Vaccine, 6, 309.
28. Takizawa, H. (2005) Bronchial epithelial cells in allergic reactions. Current Drug Targets. Inflammation and Allergy, 4, 311.
29. Wang, J., Wakeham, J., Harkness, R. & Xing, Z. (1999) Macrophages are a significant source of type 1 cytokines during mycobacterial infection. Journal of Clinical Investigation, 103, 1023.
30. Wang, J., Thorson, L., Stokes, R.W., Santosuosso, M., Huygen, K. & Zganiaz, A. (2004) Single mucosal, but not parenteral, immunization with recombinant adenoviralbased vaccine provides potent protection from pulmonary tuberculosis. Journal of Immunology, 173, 6357.
31. Yi, J.S., Du, M. & Zajac, A.J. (2009) A vital role for interleukin-21 in the control of a chronic viral infection. Science, 324, 1572.